XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

+0.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tharos who wrote (6922)	8/12/1998 12:15:00 PM
From: StockDoc	Read Replies (2) of 17367

I've been watching this stock/company since early this year. While in March or April I decided not to buy because the stock was too expensive, this time it is getting closer to a share price that I consider quite reasonable. The drug, if approved, will have a small market providing some steady cash flow. Considering the large number of shares outstanding, the potential market size (3000 patients/year @ 50% market penetration; at a cost of $ 5000/patient = $ 7.5 MM/year revenue), and a P/E of 20 to 30, $ 2/share is right on the mark. At this price I will invest. This stock has the potential for a quick temporary run up when approval (IF) is announced. An article in the Sunday NY Times would help too.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next